HER2 Overexpression as a Predictive Marker in a Randomized Trial Comparing Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil with Epirubicin in Patients with Stage I/II Breast Cancer: Long-Term Results

Mariantonietta Colozza, Maurizio Tonato, Anna Maria Mosconi et al.|Clinical Breast Cancer|2005

Cited by 19